) is a circulating pro-inflammatory and pro-oxidative protein, but its role in regulating cerebral endothelial function remains unknown. We hypothesized that in mice knockdown (KD) of angptl2, cerebral endothelial function would be protected against ANG II-induced damage. Subcutaneous infusion of ANG II (200 ng·kg Ϫ1 ·min Ϫ1 , n ϭ 15) or saline (n ϭ 15) was performed in 20-wk-old angptl2 KD mice and wild-type (WT) littermates for 14 days. In saline-treated KD and WT mice, the amplitude and the sensitivity of ACh-induced dilations of isolated cerebral arteries were similar. However, while endothelial nitric oxide (NO) synthase (eNOS)-derived O 2 Ϫ /H2O2 contributed to dilation in WT mice, eNOS-derived NO (P Ͻ 0.05) was involved in KD mice. ANG II induced cerebral endothelial dysfunction only in WT mice (P Ͻ 0.05), which was reversed (P Ͻ 0.05) by either N-acetyl-L-cysteine, apocynin, gp91ds-tat, or indomethacin, suggesting the contribution of reactive oxygen species from Nox2 and Cox-derived contractile factors. In KD mice treated with ANG II, endothelial function was preserved, likely via Nox-derived H 2O2, sensitive to apocynin and PEG-catalase (P Ͻ 0.05), but not to gp91ds-tat. In the aorta, relaxation similarly and essentially depended on NO; endothelial function was maintained after ANG II infusion in all groups, but apocynin significantly reduced aortic relaxation in KD mice (P Ͻ 0.05). Protein expression levels of Nox1/2 in cerebral arteries were similar among all groups, but that of Nox4 was greater (P Ͻ 0.05) in saline-treated KD mice. In conclusion, knockdown of angptl2 may be protective against ANG II-induced cerebral endothelial dysfunction; it favors the production of NO, likely increasing endothelial cell resistance to stress, and permits the expression of an alternative vasodilatory Nox pathway.
angiopoietin like-2; endothelium; cerebral arteries; nitric oxide; NA-DPH oxidases CARDIOVASCULAR DISEASES, INCLUDING stroke, affect more than 50% of the world population today and remain an unresolved clinical issue. Inflammation and oxidative stress synergize to promote endothelial damage, thereby chronically driving atherogenesis (13, 14) . Importantly, the cerebral vascular endothelium is highly sensitive to this deleterious environment (8, 11) . Reactive oxygen species (ROS) are signaling molecules generated by the electron transport chain (35) and are by-products of enzymes including the NADPH oxidases (18) , xanthine oxidases, and uncoupled endothelial nitric oxide (NO) synthase (eNOS) (19, 28) . In parallel, they trigger an innate anti-oxidative system to prevent their potential harmful effects (26, 29) . When this system is overwhelmed, however, endothelial damages occur and dysfunction develops, which are the first steps toward atherogenesis.
Recently, a protein identified as angiopoietin like-protein 2 (angptl2), a member of the greater angiopoietin-like family and derived from various cell types including adipocytes (31) and endothelial cells (12) , has been implicated in a number of chronic inflammatory disorders such as insulin resistance (31) , atherosclerosis (12) , and tumor progression (1, 34) . On the other hand, upregulation of angptl2 gene expression, among other genes, was recently reported in the aged brain of both rats and human, contributing to poststroke angiogenesis (5) . Information of angptl2 involvement in regulating endothelial function, however, is limited. Endothelial cell-derived angptl2 promoted aortic endothelial dysfunction in tie2-angptl2 transgenic mice, as evidenced by lower ACh-mediated aortic relaxations and lower expression of phospho-eNOS (20) . Accordingly, in angptl2 Ϫ/Ϫ mice, endothelial function and eNOS phosphorylation were preserved against a severe high-fat diet (20) . In line with this, we also observed protection against high-fat diet-induced endothelial dysfunction in angptl2 knockdown (KD) mice, through preservation of NO-mediated dilations in the femoral artery (40) . There is no report on cerebral endothelial function, and the specific impact of angptl2 on the regulation of endothelial-derived relaxing factors (EDRFs) is only emerging (40) . Through its pro-inflammatory (12, 31) and its pro-oxidative effects (2), we hypothesized that angptl2 contributes to cerebral endothelial dysfunction and the modulation of the EDRFs and that knockdown of angptl2 would increase endothelial cell stress resistance in mouse arteries. To test this hypothesis, we induced endothelial stress by chronic (14 days) infusion of a low dose of ANG II in angptl2 KD mice. We found that knockdown of angptl2 expression was associated with greater NO-dependent dilation, prevented ANG II-induced endothelial dysfunction, and induced an apocynin-and PEG-catalase-sensitive dilatory pathway, suggesting that angptl2 knockdown protects cerebral endothelial function and activates an alternative Nox dilatory pathway in the presence of ANG II, ultimately reinforcing endothelial stress resistance.
METHODS

Animals.
All angptl2 KD and wild-type (WT) littermates used in this study were from our colony and were genotyped as previously described (40) . Only male mice were used. Mice were kept under standard conditions (24°C; 12-h:12-h light/dark cycle) and were fed ad libitum with regular chow. Mice were euthanized by exsanguination under terminal anaesthesia (44 mg/kg ketamine and 2.2 mg/kg xylazine ip). All animal experiments were performed in accordance with the Guide for the Care Chronic infusion of ANG II. For ANG II studies, male mice at 20 to 22 wk of age were subcutaneously implanted with an osmotic mini-pump (Alzet 1002; Cupertino, CA) prepared with either saline or 200 ng·kg Ϫ1 ·min Ϫ1 of ANG II (Abcam; ab120183) for 14 days. At this low dose, ANG II is pro-inflammatory and pro-oxidative, but does not induce changes in blood pressure (6) , and therefore promotes endothelial dysfunction independently of its pressor effects. Mice were anesthetized and maintained throughout the procedure by inhalation of isoflurane (1-3% mixed with 97% O 2). For 3 wk before subcutaneous implantation, mice were trained by tail-cuff plethysmography (Kent Scientific, Torrington, CT) with baseline recording and during the 14 days of subcutaneous treatment, blood pressure (systolic, diastolic, and mean arterial pressures) and heart rate were noninvasively recorded on days 5, 10, 12 , and 14 as previously described (3). For reference, blood pressure was also assessed under anesthesia by both Millar catheter and tail-cuff. After euthanasia, blood was drawn from mice by cardiac puncture at terminal anesthesia and plasma was subsequently collected. Mice were weighed, and weights of their hearts and tibia length recorded. The brain was removed from the cranial cavity, and the cerebral artery (posterior cerebral artery) was harvested. The brain was then snap frozen in liquid N 2 and subsequently kept at Ϫ80°C. Posterior cerebral arteries and aorta were harvested and placed in ice-cold physiological saline solution [PSS; pH 7.4; (in mmol/l) 119 NaCl, 4.7 KCl, 1.18 KH2PO4, 1.17 MgSO4, 24.9 NaHCO3, 1.6 CaCl2, 0.023 EDTA, and 10 glucose] for in vitro endothelial function studies.
Plasma parameters. Glucose, triglyceride, and cholesterol (total, c-LDL, c-HDL) levels were measured by the Biochemistry Laboratory at the Montreal Heart Institute (Montreal, QC, Canada).
Endothelial function of cerebral arteries by pressurized arteriography. Segments of 2 to 3 mm of the posterior cerebral artery were dissected out in ice-cold PSS and cannulated at both ends in a pressurized arteriograph (Living Systems Instrumentation, St. Alban, VT) at 60 mmHg as previously described (10) . The artery segment was equilibrated for 45 min, allowing for myogenic tone to develop. Then, a single dose of phenylephrine (PE; 1 to 10 mol/l) to reach 30% to 50% of maximal diameter was added. A single cumulative concentration-response curve to ACh (0.1 nmol/l to 30 mol/l) was obtained. To inhibit NOS, NO, cyclooxygenase (COX) enzymes, H 2O2 production, mitochondrial O2
Ϫ production, to nonspecifically inhibit Nox enzymes, or to specifically inhibit Nox2, N -nitro-L-arginine (L-NNA; 100 mol/l), 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO; 100 mol/l), indomethacin (Indo; 10 mol/l), PEGcatalase (100 U/ml), mito-TEMPO (5 mol/l), apocynin (10 mol/l), or gp91ds-tat (1 mol/l; AnaSpec, Fremont, CA) were added, respectively, in the bath during equilibration (30 -45 min) and during the experiment. To eliminate oxidative stress, the antioxidant N-acetyl-Lcysteine (NAC; 10 mol/l) was added (37) . Of note, we compared endothelial function in mice with and without subcutaneous salineinfused pump implantation and found no significant differences (data not shown), and we verified that NAC has no effect per se on vascular tone (data not shown). During equilibration and experiment, the artery segment was maintained at 37°C and aerated with 12%O 2-5%CO2-83%N 2, generating an in vitro pO2 of 150 mmHg, similar to mouse blood pO 2 (10) . Dilation to sodium nitroprusside (SNP; 0.1 nmol/l to 30 mol/l) was also recorded. For vasoconstriction studies, cerebral artery was equilibrated for 45 min before a single cumulative concentration-response curve to ANG II (0.1 nmol/l to 3 mol/l) was obtained.
Fluorescence studies. Isolated mouse cerebral arteries were pressurized at 60 mmHg and incubated in oxygenated PSS at 37°C with either 5 mol/l of 5-(and-6)-chloromethyl-2=,7=-dichlorodihydrofluorescein diacetate acetyl ester (DCF-DA; a fluorescent dye-based free radical sensor; Molecular Probes) or 10 mol/l of 4,5-diaminofluorescein diacetate (DAF-2; a fluorescent dye for NO detection; Calbiochem) with or without any inhibitors-PEG-catalase (100 U/ml) or L-NNA (100 mol/l) to block H2O2 and NO production, respectively, for 30 min, after which vessels were washed three times with PSS, preconstricted with PE and dilated with 1 mol/l ACh. We previously reported that in young healthy mice, ACh-induced cerebrovascular dilation was associated with a rise in DCF-DA fluorescence, a signal that was abolished by L-NNA, PEG-catalase, pyruvate (a H2O2 scavenger), or DETC (a SOD inhibitor that increases O2 Ϫ ), but not by PTIO (a NO scavenger), demonstrating the specificity of DCF-DA for H2O2 in our experimental conditions (10) . On the other hand, we also reported that in the presence of excess levels of BH4, the cofactor of eNOS, ACh-induced dilation was associated with a rise in DAF-2, a signal that was abolished by L-NNA or PTIO, but insensitive to catalase, demonstrating the specificity of DAF-2 for NO (10) . Therefore, in our experimental conditions, DCF-DA detects H2O2 and DAF-2 detects NO. Parallel changes in cerebral arterial diameter and H2O2-fluorescence or NO-fluorescence intensities were recorded during the experiment, as described previously (10). Values are means Ϯ SE of (n) mice. WT, wild-type mice; KD, knockdown mice treated with saline or ANG II for 14 days. Values are means Ϯ SE of (n) mice.
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Structural measurements of cerebral arteries. Passive pressurediameter measurements were conducted by the pressurized arteriograph in Ca 2ϩ -free PSS and 10 mol/l SNP. Increments of intraluminal pressure of the cerebral artery (20 to 160 mmHg, with a first 20 mmHg step followed by 20-mmHg steps), were recorded to reveal lumen diameter and outer diameter, to calculate structural properties of the cerebral artery. Arterial wall thickness, lumen diameter, and wall-to-lumen ratio were presented at 60 mmHg only to represent structural properties at physiological conditions of the cerebral artery.
Endothelial function of aorta by wire myography. Thoracic aortic rings of 2 mm were mounted on 20 m tungsten wires in microvessel myographs (IMF; University of Vermont, Burlington, VT) as described previously (32) . An optimal basal tension of 1.5 g was determined for vessels while no differences in basal tension were observed among groups (data not shown). The mounted aortic ring was equilibrated for 30 to 45 min, after which the contractility of each arterial ring was determined by a 40 mmol/l KCl-PSS solution, followed by two washout periods, after which vessels were allowed to further incubate for 30 to 45 min in the absence of any drugs, or in the presence of L-NNA (100 mol/l), indomethacin (10 mol/l), apocynin (10 mol/l), or NAC (10 mol/l). Aortic segments were then preconstricted with a half-maximal effective concentration (EC 50) dose of thromboxane A2 analog 9,11-dideoxy-11␣, 9␣-epoxymethano-prostaglandin F2␣ (U46619, 0.1 nmol/l to 10 mol/l), followed by relaxation curves to ACh (0.1 nmol/l to 30 mol/l) or SNP (0.1 nmol/l to 30 mol/l). During equilibration and experiment, aortic segment was aerated with 12%O 2-5%CO2-83%N2 at 37°C.
Cerebral vessels isolation and protein analysis by Western blot. Whole brain vessels were isolated from the brain as described previously (3, 9, 24) , and 25 g of proteins in a discontinuous Laemmli buffer were loaded and separated on 10% acrylamide SDS-PAGE gels, transferred onto nitrocellulose membranes, and probed with antibodies against COX-1 (160109; Cayman, Ann Arbor, MI), COX-2 (160106; Cayman), phospho-eNOS (9571; Cell Signalling, Danvers, MA), eNOS (ab66127; Abcam, Cambridge, UK), Nox1 (PA5-27967; ThermoFisher Scientific, Rockford, IL), Nox2 (ab43801; Abcam), Nox4 (NB110-58849; Novus Biologicals, Littleton, CO), and ␣-actin (A5228; Sigma-Aldrich, St. Louis, MO). Membranes were then probed with respective anti-rabbit (GARGG-500; Peninsula Laboratories, St. Helens, UK) or anti-mouse (715-007-003; Jackson ImmunoResearch, West Grove, PA) secondary antibodies at a dilution factor of 1:10,000.
Statistical analysis. All data presented are means Ϯ SE; n is the number of mice. EC 50 is the half-maximum effective concentration as estimated by the GraphPad Prism 5.0 software for each dose-response curve, based on the variable slope sigmoidal dose-response curve formula: Y ϭ Bottom ϩ ((Top Ϫ Bottom)/(1 ϩ 10ˆ(logEC 50 Ϫ x)*Hillslope)), where "bottom" is the value for Y at the plateau bottom, "top" is value for Y at plateau top, and "hillslope" describes the steepness of the dose-response curve. E max is taken at the maximal ACh dose (30 mol/l) to induce dilation. For all experiments, the unpaired student's t-test or 2-way ANOVA followed by Bonferroni post-tests were performed as needed.
RESULTS
Similar hemodynamic parameters in both WT and angptl2
KD mice. Before treatment with ANG II, WT and KD mice showed similar blood pressures and heart rates, assessed by tail-cuff in conscious mice (Table 1) and by tail-cuff and Millar in anesthetized mice (Table 2 ). Chronic infusion of ANG II for 14 days did not affect the hemodynamic parameters in both WT and KD mice, confirming the low, sub-pressor dose of ANG II (Table 1) . Chronic infusion of ANG II did not change heart weight-to-tibia length ratios in either WT or KD mice compared with respective saline-treated animals; however, KD mice had significantly lower body weights (Table 3) , in line with literature showing lighter body weights in angptl2-deficient mice (31) , and smaller tibia length compared with WT mice with similar heart weights, resulting in significantly higher heart weight-to-mouse weight and heart weight-to-tibia length, respectively, in ANG II-treated KD compared with WT mice (Table 3) .
Similar plasma parameters between WT and angptl2 KD mice. Interestingly, nonfasting glucose level was significantly lower in ANG II-treated KD compared with WT mice. Besides Values are means Ϯ SE of (n) mice. *P Ͻ 0.05 vs. WT. Values are means Ϯ SE of (n) mice. *P Ͻ 0.05 vs. WT.
H388 that, levels of triglycerides, LDL, and HDL cholesterols remained similar among all groups (Table 4) . Myogenic tone was similar between WT and KD mice. The level of myogenic tone in isolated pressurized cerebral arteries from WT and KD mice was low, similar between strains and unaffected by ANG II treatment, but significantly increased by the NOS inhibitor L-NNA (Table 5 ). This is in accordance with our previous study (10) , where we showed that in young healthy C57Bl6 mice, spontaneous myogenic tone that developed in cerebral arteries was low, but increased in the presence of L-NNA or the NO scavenger PTIO, suggesting that dilatory eNOS-derived NO is produced and counteracts the myogenic tone. The net result is a low level of myogenic tone.
Cerebral vasodilation was preferentially driven by H 2 O 2 in WT mice and by NO in angptl2 KD mice. In the control settings, after saline infusion for 14 days in WT and KD mice, cerebrovascular endothelial function was comparable between both strains of mice (Fig. 1, A and B) , as represented by the same efficacies (E max ) and sensitivity (EC 50 ) of ACh to dilate (Table 6 ). When L-NNA was used to inhibit the NOS enzyme, Values are means Ϯ SE of (n) mice. *P Ͻ 0.05 vs. control. L-NNA, N -nitro-L-arginine. Fig. 1 . ACh-mediated endothelium-dependent vasodilation with or without incubation with either N-acetyl-L-cysteine (NAC; 10 mol/l), 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO; 100 mol/l), PEG-catalase (PEG-cat; 100 U/ml), or N -nitro-L-arginine (L-NNA; 100 mol/l) in pressurized cerebral arteries of 6-mo-old wildtype (WT; A) and knockdown (KD; B) mice subcutaneously infused with a saline solution (n ϭ 4 -10). To assess nitric oxide (NO) and H2O2 production, pressurized cerebral arteries from 6-mo-old WT mice were loaded with 4,5-diaminofluorescein diacetate (DAF-2; n ϭ 4 -6; C) and 5-(and-6)-chloromethyl-2=,7=-dichlorodihydrofluorescein diacetate acetyl ester (DCF-DA; n ϭ 5 to 6; D), respectively, in the absence or presence of L-NNA or PEG-catalase. Average increases in fluorescence intensities are shown during addition of 10 mol/l ACh. *P Ͻ 0.05 vs. WT; ‡P Ͻ 0.05 vs. no drug control (Ctrl). E: schematic dilatory pathways involved in ACh-induced dilation in cerebral arteries from WT and angptl2 KD mice. EC, endothelial cell; VSMC, vascular smooth muscle cell; AU, arbitrary units.
response to ACh was significantly blunted in both strains of mice ( Fig. 1 and Table 6 ), suggesting that endothelium-dependent dilatory responses in both WT and KD mice relied on eNOS activation. However, with the use of PTIO, a scavenger of NO, vasodilation in response to ACh was significantly blunted in KD mice, but not affected in WT mice, suggesting a role of eNOS-derived NO in KD mice only (Fig. 1, A and B; and Table 6 ). In addition, PEG-catalase significantly reduced ACh-mediated dilation in cerebral arteries from WT mice, but not from KD mice, suggesting a role of eNOS-derived H 2 O 2 in WT only (Fig. 1, A and B; and Table 6 ). We indeed previously reported the physiological uncoupling of eNOS in cerebral arteries from WT mice, in which eNOS-derived H 2 O 2 is the main EDRF (10). NAC, an antioxidant known to scavenge free radicals (30) , also reduced the vasodilation induced by ACh in WT mice, but not in KD mice, suggesting that eNOS likely produces O 2 Ϫ as the intermediate to more stable H 2 O 2 ( Fig. 1,  A and B; and Table 6 ). Altogether, these results suggest that eNOS-derived O 2 Ϫ /H 2 O 2 contributed to vasodilation in cerebral arteries from WT mice and that, in contrast, eNOS-derived NO was preferentially involved in cerebral artery dilation of KD mice.
The fact that L-NNA almost completely abolished AChinduced dilation in both WT and KD mice suggests that eNOS is the major source of O 2 Ϫ /H 2 O 2 and NO, respectively. To further confirm our pharmacological data in WT and KD mice, NO and H 2 O 2 production during ACh-induced dilation was assessed by incorporating the fluorescent ROS-reactive dyes, DAF-2 (10) and DCF-DA (7, 10), respectively (Fig. 1, C and  D) , in pressurized cerebral arteries of 6-mo-old WT and KD mice. Vasodilations to ACh resulted in significantly greater increase in NO-DAF-2 fluorescence intensities in KD compared with WT mice, a signal that was sensitive to NOS inhibitor L-NNA (Fig. 1C) . In contrast, vasodilation by ACh resulted in significantly smaller increase in H 2 O 2 -DCF-DA fluorescence intensities in cerebral arteries of KD mice, which was sensitive to PEG-catalase (Fig. 1D) . These data confirm that endothelium-dependent dilations of cerebral arteries were mainly driven by eNOS-derived NO in KD mice and by eNOS-derived H 2 O 2 in WT mice (Fig. 1E) .
To compare the downstream effects of NO on vasodilation between WT and KD mice, we tested cerebral vasodilation induced by SNP, an endothelial-independent NO donor, and found that it was similar across all groups of mice (data not shown). This suggests that endothelial function, but not vascular smooth muscle function, is modified by the knockdown of angptl2.
Infusion of a sub-pressor dose of ANG II induced cerebral endothelial dysfunction in WT but not in angptl2 KD mice. Next, we investigated the effects of a sub-pressor dose of ANG II known to induce oxidative stress and inflammation in the cerebrovasculature (6, 38) . As shown in Fig. 2 and Table 6 , after a 14-day ANG II treatment, WT mice showed, as expected, significantly impaired vasodilation to ACh compared with that of saline-treated control WT mice, whereas cerebral endothelial function was fully preserved in ANG II-treated KD mice compared with saline-treated control KD mice.
Endothelial dysfunction in ANG II-treated WT mice was reversed in the presence of NAC (P Ͻ 0.05), but not of Mito-TEMPO (Fig. 3A and Table 6 ), suggesting that ANG II-induced endothelial dysfunction was due to increased oxidative stress independent of the mitrochondria. PEG-catalase and L-NNA did not affect endothelial dysfunction induced by ANG II (Fig. 3A and Table 6 ), suggesting that ANG II-induced oxidative stress blunted eNOS function. In contrast, endothelial dysfunction in ANG II-treated WT mice was reversed by both apocynin and gp91ds-tat (P Ͻ 0.05; Fig. 3B and Table 6 ), a (7) 7.7 Ϯ 0.5 (7) 43 Ϯ 7 (7) 8.5 Ϯ 0.1 (7) 48 Ϯ 9 (7) 7.6 Ϯ 0.5 (7) Values are means Ϯ SE of (n) mice. NAC, N-acetyl-L-cysteine; Indo, indomethacin; PTIO, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide; ND, not determined. Two-way ANOVA with Bonferreoni post-test: *P Ͻ 0.05 vs. WT ϩ Saline; †P Ͻ 0.05 vs. WT ϩ ANG II; ‡P Ͻ 0.05 vs. control; §P Ͻ 0.05 vs. KD ϩ Saline. nonspecific inhibitor of Nox and a specific Nox2 inhibitor, respectively, suggesting that ANG II-induced superoxide generation from Nox2. The difference between saline-treated and ANG II-treated WT mice is the activation of Nox2, likely producing in another cellular compartment large amounts of superoxide that is not converted to dilatory H 2 O 2 (insensitive to the effect of PEG-catalase), thus creating a pro-oxidative deleterious environment. Accordingly, indomethacin also reversed endothelial dysfunction in ANG II-treated WT mice (P Ͻ 0.05; Fig. 3C and Table 6 ), suggesting possible detrimental effects of COX-derived contractile EDCF such as thromboxane A 2 . Indeed, COX produces both dilatory (prostacyclin) and contractile (thromboxane A 2 ) factors, but in the presence of ROS, prostacyclin synthase can be nitrosylated and inactivated (41) . In turn, this reveals the contractile component of COX activity, sensitive to indomethacin. Altogether, these data suggest that in cerebral arteries from WT mice, ANG II induced superoxide generation from Nox2, which in turn favored EDCF production and endothelial dysfunction (Fig. 3D) .
In KD mice, ANG II did not induce cerebral endothelial dysfunction (Fig. 2) . NAC or Mito-TEMPO, as expected, did not counteract the vasodilating effects of ACh in these mice ( Fig. 4A and Table 6 ), whereas L-NNA reduced (P Ͻ 0.01) vascular sensitivity to ACh (Table 6) , suggesting preserved eNOS function in ANG II-treated KD mice. However, PEGcatalase also significantly reduced ACh-induced dilation (Fig.  4A and Table 6 ), suggesting the involvement of H 2 O 2 as a dilatory pathway in ANG II-treated KD mice that was not observed in saline-treated KD mice. Apocynin also significantly decreased the efficacy of ACh to vasodilate (P Ͻ 0.05), as depicted in Fig. 4B and Table 6 , whereas the Nox2 inhibitor gp91ds-tat was ineffective. Therefore, the combined contribution of eNOS-derived NO and Nox-derived H 2 O 2 likely preserved the dilatory response of cerebral arteries from ANG II-treated KD mice. Indomethacin did not affect the response to ACh, suggesting that neither prostacyclin nor thromboxane A 2 significantly regulates tone (Fig. 4C and Table 6 ). Thus these data support the involvement of H 2 O 2 as a complementary dilatory pathway in cerebral arteries from ANG II-treated KD mice (Fig. 4D) , but not ANG II-treated WT mice.
Of note, vasoconstriction of cerebral arteries in response to acute addition of ANG II in the experimental bath was similar between WT and KD mice (data not shown). In addition, response to SNP in ANG II-infused mice was not different among all the groups (data not shown). Meanwhile, structural properties of cerebral arteries, such as arterial lumen diameter and wall thickness, among different treatment groups of mice of both strains remained similar: arteries from WT mice were structurally similar to those from KD mice (Fig. 5) . Endothelial function in the aorta remained unchanged after ANG II infusion, but recruited prostacyclin in angptl2 KD mice. Aortic endothelial function was similar between salinetreated WT and KD mice (Fig. 6, A and B, and Table 7 ). In contrast with resistance cerebral arteries, aorta of saline-treated WT and KD mice both relied similarly on NO to relax (Fig. 6 , A and B, and Table 7 ), as L-NNA significantly reduced AChmediated relaxation (Fig. 6, A and B) , while the antioxidant NAC had no effect (Fig. 6, C and D) . Although we observed significant detrimental effects of a chronic sub-pressor dose of ANG II in the cerebral arteries of WT mice, aortic endothelial function after ANG II infusion was unaffected (Fig. 6, A and B, and Table 7 ). Unexpectedly, apocynin inhibited dilation in both saline-and ANG II-treated WT mice (Fig. 6E and Table 7 ). On the other hand, and as observed in cerebral arteries, apocynin was only effective in inhibiting relaxation in ANG II-treated, but not saline-treated, KD mice ( Fig. 6F and Table 7 ), suggesting again that Nox also contributed to the vasorelaxation in these ANG II-treated KD mice. Furthermore, only in angptl2 KD mice treated with ANG II, indomethacin, a COX inhibitor, significantly reduced efficacy of ACh-induced response (Fig. 6 , G and H, and Table  7 ), suggesting possible recruitment of prostacyclin to mediate vasodilation. Aortic relaxations to SNP were similar across all groups (data not shown).
Protein expression of Nox4 in cerebral vessels was greater in control KD mice, whereas Nox1 and Nox2 expressions were the same among all groups.
Because we observed different responses to various inhibitors in the cerebral endothelial function studies, we further investigated protein expression of several enzymes involved in either vasodilation or ROS generation (Fig. 7) . Isolation of cerebral vessels proteins revealed that although basal expression levels of Nox1 and Nox2 were similar across all groups of mice, basal Nox4 protein expression was greater in KD mice treated with saline only (Fig. 7) . In addition, the ratio of phospho-eNOS to total eNOS expressions, COX-1, and -2 levels were also similar across all groups (Fig. 7) .
DISCUSSION
Our report is the first to suggest that in cerebral arteries, knockdown of angptl2 switches eNOS activity from an O 2 Ϫ / H 2 O 2 to NO producing enzyme and that this confers, at least partly, endothelial cell resistance to the stress imposed by ANG II. We also show that knockdown of angptl2 likely modifies the intracellular contribution of the Nox pathway, i.e., Nox-derived H 2 O 2 (sensitive to apocynin and PEG-catalase) in cerebral arteries from ANG II-treated angptl2 KD mice, versus Noxderived O 2 Ϫ (sensitive to apocynin and gp91ds-tat) in ANG II-treated WT mice. Altogether, these data strongly suggest that knockdown of angptl2 protects the endothelium through remodelling of the EDRFs and the recruitment of an additive dilatory Nox pathway, leading to preserved cerebral endothelial function under ANG II stimulation.
The loss of NO-dependent relaxation, anti-adhesion, and anti-aggregant activities is the main criteria defining endothelial dysfunction. In two recent reports, it was shown that angptl2 promoted endothelial dysfunction in a pro-atherogenic environment, decreased relaxation and expression of phosphoeNOS (20) , increased leukocytes adhesion, and ultimately accelerated atherogenesis (12) . Our demonstration that knockdown of angptl2 favors NO-dependent dilation in cerebral arteries therefore suggests that angptl2 plays a role in reducing endothelial cell stress resistance. Indeed, endothelium-dependent dilation of isolated cerebral arteries from angptl2 KD mice was sensitive to the NO scavenger PTIO and associated with a greater amount of eNOS-derived NO production in response to ACh. This is in contrast with WT mice, whose cerebral vasodilation has been shown by us to depend mainly on eNOS-derived H 2 O 2 (10). We indeed previously demonstrated that in cerebral arteries isolated from young and healthy mice, eNOS was physiologically uncoupled and that H 2 O 2 derived from eNOS activity was an EDRF in these arteries (10) . This uncoupling of eNOS was not due to low levels of the cofactor BH 4 and did not favor the monomer configuration of eNOS, both conditions observed during pathological eNOS uncoupling (10) . In addition, we previously demonstrated that this eNOS-derived H 2 O 2 -dependent response was absent in cerebral arteries from eNOS Ϫ/Ϫ mice and was also absent in peripheral arteries such as gracilis arteries, showing that this apparent eNOS uncoupling was specific to the cerebrovasculature (10) . The finding that cerebral endothelial function in KD was mainly driven by NO suggests that knockdown of angptl2 protects the cerebral endothelium. Moreover, the impact of knocking down angptl2 specifically affected endothelial function as direct stimulation of the NO pathway using SNP in smooth muscle cell led to similar dilatory response in both strains.
ANG II, at a sub-pressor dose, is known to impose lowgrade inflammation and oxidative stress, leading to endothelial dysfunction (6) . We previously reported that ANG II stimulated free radical production in isolated mouse resistance arteries, as well as COX activity (22) . Therefore, protective or reversible effects by NAC and indomethacin were expected and reflect a global disruption of the redox regulation by ANG II. In cerebral arteries from WT mice, ANG II produced endothelial dysfunction that was dependent on the combined effects of oxidative stress and the Nox systems (6, 36) , as well as the COX systems, since the addition of either the antioxidant NAC, apocynin, gp91ds-tat, or indomethacin reversed this dysfunction. Thus, in cerebral arteries from WT mice, ANG II induced superoxide generation from Nox2, which in turn favored EDCF production and endothelial dysfunction. We speculated that in angptl2 KD mice, the cerebral endothelium would be less sensitive to ANG II-dependent stress because of the augmented NO production. Our results support this hypothesis, since there was complete prevention of ANG II-induced endothelial dysfunction in cerebral arteries from angptl2 KD mice. It is important to stress that ANG II induced a reversible cerebral endothelial dysfunction, as shown by the normalized dilatory response in the presence of antioxidant NAC, indomethacin, and apocynin in WT mice. It has been reported that angptl2 was involved in plasma membrane recycling of type 1 angiotensin II receptor (AT 1 R) (15) (16) (17) 34) and that, in isolated perfused kidneys, renal vascular resistance in response to ANG II was lower in angptl2 knock-out mice (25) . We observed, in contrast, that vasoconstriction to ANG II was similar in both WT and KD mice. This suggests that it is unlikely that angptl2 directly interacts with the smooth muscle cell ANG II/AT 1 R pathway, at least in cerebral arteries.
Apocynin, a nonspecific Nox inhibitor (27) , generated opposite responses to ACh-dependent dilation: whereas in ANG II-treated WT mice, apocynin expectedly restored a normal endothelial function (36) , it reduced ACh-dependent dilation of cerebral arteries isolated from ANG II-treated KD mice. The more specific Nox2 inhibitor gp91ds-tat was also able to reverse endothelial dysfunction in ANG II-treated WT, without any effects in KD mice. Altogether, this supports a paradigm that angptl2 regulates the Nox pathway. Because Nox1 and Nox2 produce superoxide and Nox4 produces dilatory H 2 O 2 (23), it is possible that knockdown of angptl2 leads to a shift from Nox1/2 to Nox4. This is supported by the lack of effect of NAC in ANG II-treated KD mice, an antioxidant capable of scavenging eNOS-or Nox2-derived O 2 Ϫ but not Nox4-derived infusion of ANG II at a sub-pressor dose, with the exception that Nox4 was expressed at a higher levels in angptl2 KD mice treated with saline. Collectively, protein expressions of the Nox isoforms failed to explain the effects of apocynin and gp91ds-tat to affect cerebral endothelial function in KD mice treated with ANG II. Intriguingly, apocynin has been shown to prevent the translocation of the cytosolic component p47phox to Nox in endothelial cells (21) , so that Nox isoform expressions alone in these mice may not reflect functional differences observed in cerebral arteries. To our knowledge, however, our study is the first to propose a link between Nox and angptl2.
Because of the heterogeneity of endothelial function in the vasculature, we studied in parallel the response of the endothelium in the aorta. Under control conditions, both WT and KD mice similarly depended on NO to relax, as shown by parallel inhibition of ACh-mediated dilation by L-NNA and by the lack of inhibitory effect of NAC. Most recently, another group similarly found comparable aortic endothelial function between angptl2 knock-out and WT mice when fed a normal chow (20) . In contrast, when mice were exposed to a high-fat diet, endothelial dysfunction induced by the diet was lower in angptl2 knock-out mice than in WT mice, and this protection was associated with a lower eNOS deactivation (20) . In our study, endothelial function in the aorta was not affected by ANG II, in either WT or angptl2 KD mice. The fact that the aortic endothelium mostly produces NO in both strains of mice, unlike that of cerebral arteries isolated from WT mice, could explain its greater resistance against the stress induced by ANG II. Apocynin surprisingly reduced ACh-induced relaxation of aorta from WT mice, whether or not treated with ANG II, implicating a differential contribution of Nox in the regulation of vascular tone between cerebral resistance and peripheral conductance arteries from WT mice. Such strong differences are expected based on the important heterogeneity of the endothelium in the vasculature, especially when one considers the unique features of the cerebral circulation (33) and the complexity of the Nox signaling pathways (4). Importantly, the significant inhibitory effect of apocynin in ANG II-treated angptl2 KD mice implies the likely contribution of Nox as a compensatory dilatory pathway when angptl2 is knocked-down. Therefore, as a general feature, we propose that the regulation of the Nox pathways is a target of angptl2 in the endothelium. Nonetheless, ANG II led to a compensatory response of the aortic endothelium, as the nonselective COX inhibitor indomethacin significantly reduced maximal dilation in the aorta of angptl2 KD mice only, indicating possible recruitment of prostacyclin-dependent vasorelaxation, which was not observed in WT littermates. This could be one of the beneficial effects of knocking-down levels of angptl2, since prostacyclin is known for its vascular protective properties.
One of the main limitations of the present study involves recognized deficiencies of the fluoroprobes used, especially DCF-DA. It has been reported that DCF could by itself reduce oxygen and cause production of superoxide at a high rate constant (39) , and, therefore, may not be fully specific for H 2 O 2 . Our group, however, has previously reported that in young and healthy mice, similar to those used in the present study, ACh-induced cerebral vasodilation was associated with a rise in DCF-DA fluorescence, which was sensitive to L-NNA, PEG-catalase, and H 2 O 2 scavenger pyruvate, as well as superoxide dismutase inhibitor DETC, but not to NO scavenger PTIO (10) , thus demonstrating the greater relative specificity of DCF-DA to H 2 O 2 versus NO or its derived reactive nitrogen species.
In conclusion, our results suggest that the knockdown of angptl2 in mice is able to preserve endothelial integrity when challenged with a sub-pressor dose of ANG II. Possible mechanisms may involve different contributions of EDRFs, since there is greater dependence on NO in angptl2 KD mice compared with WT mice that favor O 2 Ϫ /H 2 O 2 in cerebral vasodilation. In the aorta, knockdown of angptl2 may contribute to recruitment of vasodilating effects of prostacyclin. In addition, knockdown of angptl2 may be associated with beneficial effects of a Nox, likely Nox4, an isoform that predominantly produces dilatory H 2 O 2 . Taken together, preventing the demonstrated rise of angptl2 through age (20) and atherosclerosis (12, 20) may emerge as a new therapeutic concept to increase endothelial cell stress resistance and delay atherogenesis. 
